Because lipotropic injections can vary by formulation, its important to review the ingredients, dosing schedule, and intended use with a licensed healthcare provider to determine which formula best fits your needs
Oral NR (strongest human RCT base) Multiple RCTs (Martens 2018, Conze 2019, Dollerup 2018, Brakedal 2022) consistently raised blood NAD+ with favorable tolerability at doses up to 1,000 mg/day
The tirzepatide or Mounjaro and Zepbound comes in two formulations now
It is easy to take a dropper full each day, and the taste is mild and not bad at all
Phase Maintenance Weeks 25+ Tirzepatide 15.0 mg/week Cagrilintide 2.4 mg/week Notes Full 3-receptor coverage if tolerated
Clinical leadership from a licensed PA-C